Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.135 USD | -0.44% | -0.44% | -36.24% |
05-10 | Transcript : Protalix BioTherapeutics, Inc., Q1 2024 Earnings Call, May 10, 2024 | |
05-10 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.24% | 83.58M | |
+29.60% | 48.16B | |
-0.69% | 41.73B | |
+42.66% | 41.03B | |
-5.26% | 28.77B | |
+10.14% | 25.59B | |
-22.61% | 18.96B | |
+9.02% | 12.92B | |
+29.25% | 12.03B | |
-1.90% | 11.77B |
- Stock Market
- Equities
- PLX Stock
- News Protalix BioTherapeutics, Inc.
- Protalix BioTherapeutics' Joint Resubmission of Application for Fabry Disease Treatment Gets FDA Acceptance